REFERENCES
- Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985;92(4):467–471
- London NJ, Garg SJ, Moorthy R, Cunningham ET Jr. Drug-induced uveitis. J Ophthalmic Inflamm Infect 2013;3(1):43
- Patel DV, Horne A, House M, et al. The incidence of acute anterior uveitis after intravenous zoledronate. Ophthalmology 2013;120(4):773–776
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245
- Belliveau MJ, Almeida DR, Urton TE. Acute anterior uveitis following zoledronic acid infusion for osteoporosis. Can J Ophthalmol 2012;47(5):e22–e23
- Durnian JM, Olujohungbe A, Kyle G. Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy. Eye (Lond). 2005;19(2):221–222
- Colucci A, Modorati G, Miserocchi E, et al. Anterior uveitis complicating zoledronic acid infusion. Ocul Immunol Inflamm 2009;17(4):267–268
- El Saghir NS, Otrock ZK, Bleik JH. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer. BMC Cancer 2005;5:156
- Gilhotra JS, Gilhotra AK, Holdaway IM, Donaldson ML. Acute retinal pigment epitheliitis associated with intravenous bisphosphonate. Br J Ophthalmol 2006;90:798–799
- Davis JL, Madow B, Cornett J, et al. Scale for photographic grading of vitreous haze in uveitis. Am J Ophthalmol 2010;150(5):637–641